Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. Bases follow-up testing on the difference between bilirubin level and the phototherapy threshold. No more risk zones! Raises thresholds for phototherapy and exchange transfusion. Includes gestational age and risk factors for neurotoxicity in the thresholds.

    • Disclaimer

      Disclaimer - BiliTool - Newborn values:

    • BiliTool EMR

      eTCOC (optional). The end-tidal carbon monoxide (corrected)...

    • FAQ

      Can I use BiliTool with transcutaneous bilirubin? TcB...

    • Subscribe

      Subscribe - BiliTool - Newborn values:

    • About

      About - BiliTool - Newborn values:

    • Latest Features

      October-November 2022 Updates. We are pleased to announce...

    • Neurotoxicity Risk Factors

      Neurotoxicity Risk Factors - BiliTool - Newborn values:

    • BiliTool

      Trending Bilirubin. BiliTool can trend bilirubin over time...

  2. 5 sie 2022 · The 2004 guideline focused on infants ≥35 weeks’ gestation. This gestational age range includes most newborn infants cared for, and subsequently followed by, general pediatricians and other primary care clinicians on well newborn services or mother-baby care units.

  3. The new nomogram included 2 orders of magnitude more patient data and generally agreed with the 1999 nomogram. Differences included higher 75th and 90th percentile TSB values after 60 hours, higher values for lower gestational age, lower values for Black babies, and higher values for Asian babies.

  4. 4 sty 2021 · We provide the first globally derived transcutaneous bilirubin nomogram that reflects the natural history of early neonatal bilirubinemia in neonates ≥35 weeks gestation.

  5. Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation. Features. Neurotoxicity risk factors absent, present, or both. Plot multiple time points to assess trends.

  6. When using this nomogram, remember that "risk" refers to the risk of a subsequent bilirubin level in that infant >95th percentile for age.

  7. The management of neonatal jaundice includes the assessment of bilirubin laboratory values, consideration of patient-specific risk factors, and plotting on a bilirubin nomogram reference to determine risk and guide therapy.